REIMBURSEMENT UNRAVELLED: Why blood glucose monitoring products are reimbursement anomalies
This article was originally published in Clinica
Executive Summary
In the fifth instalment of Clinica’s new reimbursement series, Dr Mark Charny explains that careful and detailed consideration of the reimbursement, prescribing and purchasing regulations in each market is required to develop a coherent marketing strategy for blood glucose meters and test strips in Europe. He focuses here primarily on the UK, German, French and Italian markets with a glance too at Spain and Sweden